Esperion Therapeutics, Inc. (ESPR) has 12 identified peers for comparison in the Healthcare sector. Peers include AGRX, ALKS, ANIP, AVDL, COLL, CTLT and others.
ESPR has a market capitalization of $426.21M, compared to an average peer market cap of $4.51B. ESPR is notably smaller than its average peer.
